欢迎来到CSNpharm!产品仅用于科研!

400-920-2911 sales@csnpharm.cn

0

您的位置 : 首页  /  Cell Cycle  /  DHFR  /  Iclaprim

CAS No.: 192314-93-5

Iclaprim Catalog No. CSN21969

Synonyms: AR-100;RO-482622;AR-100.001

Iclaprim is a new selective bacterial dihydrofolate reductase inhibitor, which can inhibit the growth of S. aureus (MRSA) with an MIC90 of 0.06 μg/mL.

规格 价格 促销价格 库存 数量
纯度 & 质量文件 批次:

靶点选择性

生物活性

  • 临床研究
  • NCT号适应症或疾病临床期招募状态预计完成时间地点
    NCT00303550Skin Diseases, BacterialPhase 3Completed-United States, Illinois ... more >> Edward Hospital & Health Services Naperville, Illinois, United States, 60540 United States, Wyoming Wyoming Medical Center Casper, Wyoming, United States, 82601 Collapse <<
    NCT00543608Hospital-Acquired Pneumonia ... more >> Ventilator-Associated Pneumonia Health-Care-Associated Pneumonia Collapse <<Phase 2Terminated(Trial terminated du... more >>e to financial resource limitations) Collapse <<May 2009-
    NCT02600611Skin Structures and Soft Tissu... more >>e Infections Collapse <<Phase 3Completed--
  • 更多

实验方案

技术信息

CAS号 192314-93-5 储存条件
分子式 C19H22N4O3 运输 蓝冰
分子量 354.40 别名 AR-100;RO-482622;AR-100.001

大规格询价

号为必填项

姓名: 邮箱: 手机号:
留言:
   提交
联系
我们